Chen et al [15] demonstrated that detection of BRAF mutations in lymph nodes involved with metastatic malignant melanoma was particularly challenging when there was a low tumor cell burden, such as with small subcapsular metastatic deposits or infiltrative tumor cells in a background of small lymphocytes. The gene discussed is BRAF; the disease is neoplasm.